Your browser doesn't support javascript.
loading
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.
Allanore, Yannick; Vonk, Madelon C; Distler, Oliver; Azuma, Arata; Mayes, Maureen D; Gahlemann, Martina; James, Alexandra; Kohlbrenner, Veronika; Alves, Margarida; Khanna, Dinesh; Highland, Kristin B.
Afiliación
  • Allanore Y; Department of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France yannick.allanore@me.com.
  • Vonk MC; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Distler O; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • Mayes MD; Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, Texas, USA.
  • Gahlemann M; Inflammation Medicine, Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland.
  • James A; Elderbrook Solutions GmbH, Bietigheim-Bissingen, Germany.
  • Kohlbrenner V; Inflammation Medicine, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
  • Alves M; Inflammation Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Khanna D; Department of Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA.
  • Highland KB; Pulmonary Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Ann Rheum Dis ; 81(12): 1722-1729, 2022 12.
Article en En | MEDLINE | ID: mdl-35973804

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Fibrosis Pulmonar Idiopática Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Fibrosis Pulmonar Idiopática Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Francia